Please login to the form below

Not currently logged in
Email:
Password:

Antisense secures funding

Germany-based Antisense Pharma has secured new funding as it begins an international trial of its pancreatic cancer treatment

Antisense Pharma has completed its latest round of fundraising, with its main investor MIG Funds 2, 3 and 9, as well as GAF increasing their share capital by approximately €8m.

The German company has launched a second international clinical trial of trabedersen, a second-line treatment for pancreatic cancer. Michael Motschmann, chief executive of MIG Verwaltungs, said: "Trabedersen could give new hope to patients suffering from this extremely aggressive type of cancer and open up a greatly needed but thus far completely vacant market niche along with its corresponding high revenue potential.

"At the same time, this means a risk reduction for the development of trabedersen, as this medication now has several marketing opportunities if the trials are successful. Furthermore, there is a potential for added value since new markets can be opened up."

The company has also announced that it chief executive Dr Karl-Hermann Schlingensiepen has moved to an advisory position. Dr Hubert Heinrichs, managing director and chief medical officer of Antisense Pharma, will assume the position as acting CEO.

6th July 2011

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Nobull Communications

Switched on Creative Communications. With an encyclopedic working knowledge of pharmaceutical industry rules and regulations, we create dynamic, intuitive and...

Latest intelligence

PM Society Digital Awards – the power of together
Our chief executive, Emma Statham, writes about the value of awards and the power of together....
Seduction_feature_image_thumb.jpg
Seduce anyone in four simple steps
You know the health of the global economy is dependent on our ability to seduce one another – don’t you? And you know that we need to be able to...
What Would Jeremy Do? : Assessing the impact of a Corbyn-led Labour government
GK Strategy are delighted to announce the launch our latest briefing paper entitled ‘What Would Jeremy Do? Assessing the impact of a Corbyn-led Labour government’....

Infographics